Profile
DXR ISRG BDX ALC RMD WST
Company Name Daxor Corporation Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. ResMed Inc. West Pharmaceutical Services, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $43.53M $156.82B $68.58B $46.06B $28.95B $20.74B
Employees 0.04K 13.68K 70.00K 25.00K 10.14K 10.60K
CEO Mr. Michael Richard Feldschuh Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM Mr. Eric M. Green
Ratings
DXR ISRG BDX ALC RMD WST
Quant Rating Score 4 3 3 3 3 3
Quant Rating Buy Neutral Neutral Neutral Neutral Neutral
Trading
DXR ISRG BDX ALC RMD WST
Last Close $9 $441.3 $237.3 $93.37 $197.04 $284.76
High 52 $10.1 $461.12 $283.59 $93.36 $225.35 $413
Low 52 $7.19 $258.49 $221.47 $69.56 $134.65 $277.16
Price vs. 52 Week High -10.89 % -4.3 % -16.32 % 0.01 % -12.56 % -31.05 %
Price vs. 52 Week Low 25.17 % 70.72 % 7.15 % 34.23 % 46.33 % 2.74 %
Total Return
DXR ISRG BDX ALC RMD WST
1 Month Return -6.15 % -0.86 % 2.75 % 4.08 % 2.85 % -13.38 %
3 Month Return -6.74 % 17.58 % 2.48 % 18.53 % -9.64 % -20.99 %
6 Month Return 4.65 % 17.76 % 0.27 % 22.86 % 3.62 % -21.2 %
9 Month Return 15.38 % 70.4 % -5.68 % 33.37 % 46.33 % -11.27 %
YTD Return -6.15 % 30.81 % -2.68 % 19.52 % 14.54 % -19.13 %
1 Year Return -8.54 % 36.39 % -16.32 % 10.11 % -11.04 % -19.76 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DXR ISRG BDX ALC RMD WST
Dividend Yield Percentage (TTM) - - 1.58 % 0.28 % 0.97 % 0.21 %
Dividend Paid and Capex Coverage Ration (TTM) - 1.16 % 2.05 % 1.66 % 2.97 % 1.66 %
Dividend Per Share (TTM) - - 3.76 % 0.26 % 1.92 % 0.6 %
Payout Ratio (TTM) - - 82.6 % 11.25 % 28.85 % 11.07 %
Growth
DXR ISRG BDX ALC RMD WST
Asset Growth 15.23 % 19.02 % -0.29 % 1.35 % 32.49 % 5.88 %
Gross Profit Growth 558.85 % 12.71 % -3.62 % 18.11 % 16.37 % -0.62 %
Revenue Growth 448.16 % 14.49 % 2.66 % 15.77 % 18.02 % 2.18 %
Revenue 3 Year 3050.6 % 63.36 % 10.28 % 46.5 % 40.45 % 36.66 %
Revenue 5 Year 3142.98 % 85.79 % 9.38 % 39.86 % 75.54 % 70.83 %
Revenue 10 Year 364.28 % 223.26 % 63.97 % 53.48 % 171.6 % 101.93 %
EBIT Growth -93.72 % 45.86 % -7.49 % 87.58 % 13.15 % -7.9 %
Net Income Growth -94.58 % 35.98 % -16.58 % 190.75 % 15.15 % 1.28 %
Net Income 3 Yeari Growth Per Share 113.99 % 69.43 % 65.46 % 281.94 % 41.99 % 70.48 %
Net Income 5 Yeari Growth Per Share 125.6 % 54.83 % 330.62 % 525.33 % 176.65 % 185.26 %
Net Income 10 Yeari Growth Per Share 103.02 % 175.41 % -21.76 % 225.89 % 184.65 % 394.98 %
Operating Income Growth -93.72 % 45.86 % -7.49 % 87.58 % 13.15 % -7.9 %
Operating Cash Flow Growth (CFG) -732.08 % 21.67 % 13.52 % 21.73 % 97.44 % 7.25 %
Operating 3 Year CFG -122.26 % 22.09 % -17.7 % 78.55 % -15.01 % 63.45 %
Operating 5 Year CFG -293.13 % 50.62 % -5.85 % 28.82 % 33.54 % 167.61 %
Operating 10 Year CFG 37.49 % 111.85 % 35.21 % 11.44 % 67.64 % 229.88 %
EPS Growth -95.23 % 37.63 % -16.19 % 201.43 % 14.61 % 1.4 %
EPS Diluted Growth -95.23 % 37.81 % -15.99 % 198.57 % 14.91 % 1.94 %
Book Value Per Share 3.52 % 21.29 % 1.5 % 4.44 % 22.3 % 7.45 %
Share Holder 3 Year Equity Growth Per Share 84.39 % 36.28 % 5.73 % 8.65 % 62.66 % 54.52 %
Share Holder 5 Year Equity Growth Per Share 110.38 % 93.27 % 10.89 % -9.73 % 95.11 % 105.22 %
Share Holder 10 Year Equity Growth Per Share 13.89 % 290.63 % 248.77 % -13.54 % 149.77 % 197.74 %
Dividend Per Share Growth - - 2.5 % 15.62 % 4.77 % 5.5 %
Dividend 3 Year Growth Per Share - - 5.8 % - 12.84 % 17.87 %
Dividend 5 Year Growth Per Share - - 8.45 % - 25.93 % 34.66 %
Dividend 10 Year Growth Per Share -100 % - 96.74 % - 158.81 % 99.23 %
Debt Growth -38.52 % -4.26 % -1.16 % 1.48 % 72.19 % -2.8 %
Free Cash Flow Growth -732.08 % -21.79 % 27.41 % 21.44 % 186.66 % -5.67 %
Updated On 31 Dec 2023 31 Dec 2023 30 Sep 2023 31 Dec 2023 30 Jun 2023 31 Dec 2023
Profitability
DXR ISRG BDX ALC RMD WST
Gross Profit Margin TTM 98.75 % 66.86 % 41.25 % 55.6 % 57.28 % 35.73 %
Return on Assets TTM 26.99 % 12.57 % 2.46 % 3.54 % 14.06 % 15.04 %
Return on Equity TTM 29.24 % 15.36 % 5.19 % 5.14 % 21.92 % 19.08 %
Return on Capital Employed TTM -0.33 % 12.88 % 4.64 % 5.08 % 20.09 % 20.72 %
Net Income Per EBT TTM 6706.06 % 93.85 % 81.08 % 108.82 % 80.95 % 85.87 %
EBT Per Ebit TTM -123.76 % 114.25 % 75.69 % 69.52 % 97.52 % 103.3 %
EBIT Per Revenue TTM -0.33 % 25.79 % 11.02 % 14.3 % 27.31 % 20.57 %
Cash Flow To Debt Ratio TTM -1088.95 % 1671.71 % 20.88 % 32.36 % 116.24 % 331.45 %
Receivables Turnover TTM 2442.03 6.09 7.7 5.28 5.44 5.73
Payables Turnover TTM 4.22 12.91 2.38 5.26 10.7 8.73
Inventory Turnover TTM - 1.81 3.59 1.85 2.29 4.41
Fixed Asset Turnover TTM - 183.94 % 299.14 % 206.93 % 647.17 % 175.95 %
Asset Turnover TTM 99.43 % 45.48 % 36.41 % 32.77 % 65.23 % 82.44 %
Operating Cash Flow Per Share TTM -1.71 4.05 12.99 3.33 8.16 10.31
Free Cash Flow Per Share TTM -1.71 0.54 10.45 1.57 7.29 4.89
Cash Per Share TTM - 1340.06 % 1112.54 % 232.28 % 176.54 % 611.23 %
Operating Cash Flow Sales Ratio TTM -23.73 % 18.96 % 19.08 % 16.99 % 26.97 % 26.15 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 13.43 % 80.46 % 47.02 % 89.38 % 47.46 %
Cash Flow Coverage Ratios TTM -1088.95 % 1671.71 % 20.88 % 32.36 % 116.24 % 331.45 %
Price To Free Cash Flows Ratio TTM -5.29 812.95 22.66 59.52 27.02 58.09
Price To Operating Cash Flows Ratio TTM -5.26 109.1 18.27 28.01 24.16 27.63
Price Cash Flow Ratio TTM -5.26 109.1 18.27 28.01 24.16 27.63
Income Statement (TTM)
DXR ISRG BDX ALC RMD WST
Revenue $0.03B $7.12B $19.37B $10.09B $4.22B $2.95B
Gross Profit $0.03B $4.73B $8.17B $5.61B $2.36B $1.13B
Gross Profit Ratio 99.49% 66.39% 42.17% 55.57% 55.78% 38.28%
EBITDA $0B $2.19B $4.72B $2.56B $1.34B $0.88B
Net Income $0B $1.8B $1.48B $0.97B $0.9B $0.59B
EPS Diluted 0.06 5.03 4.94 2.09 6.09 7.88
Balance Sheet (MRQ)
DXR ISRG BDX ALC RMD WST
Long Term Debt $0B $-0.08B $14.74B $4.59B $1.55B $0.16B
Total Liabilities $0B $2.04B $26.98B $8.99B $2.62B $0.95B
Total Equity $0.03B $13.4B $25.8B $20.62B $4.13B $2.88B
Total Investments $0.03B $4.59B $0.01B $0.28B $-0.13B $0.21B
Total Debt $0B $0.09B $15.88B $5.14B $1.58B $0.31B
Total Assets $0.03B $15.44B $52.78B $29.6B $6.75B $3.83B
Cash Flow Statement (TTM)
DXR ISRG BDX ALC RMD WST
Net Income $0B $1.82B $1.53B $1.04B $0.9B $0.59B
Inventory $0B $-0.71B $-0.02B $-0.29B $-0.25B $-0.01B
Dividends Paid $0B $0B $-1.11B $-0.12B $-0.26B $-0.06B
Operating Cash Flow $-0.01B $1.81B $2.99B $1.48B $0.69B $0.78B
Capital Expenditure $0B $-1.06B $-0.87B $-0.91B $-0.13B $-0.36B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 2.46
ALC Alcon Inc. 93.37
ANGO AngioDynamics, Inc. 7.65
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 146.66
ATRC AtriCure, Inc. 22.1
ATRI Atrion Corporation 457.65
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 1.42
AZTA Azenta, Inc. 60.22
BAX Baxter International Inc. 35.51
BDX Becton, Dickinson and Company 237.3
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.81
BLFS BioLife Solutions, Inc. 24.04
COO The Cooper Companies, Inc. 93.21
EKSO Ekso Bionics Holdings, Inc. 1.3
FEMY Femasys Inc. 1.14
GCTK GlucoTrack, Inc. 1.36
GMVD G Medical Innovations Holdings Ltd 0.1835
ETFs With Exposure to DXR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 269.69
VTSAX Vanguard Total Stock Market Index Fund 0 131.27
VITSX Vanguard Total Stock Market Index Fund 0 131.29
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 246.27
Unlock